Paper Details
- Home
- Paper Details
Monitoring tacrolimus toxicity following Paxlovid administration in a liver transplant patient.
Author: BatesPhillip, Korpi-SteinerNichole, MaynardRobert D
Original Abstract of the Article :
Maintaining therapeutic plasma tacrolimus concentrations is essential for mitigating potential solid organ transplant rejection and preventing toxic adverse side effects. While patients can benefit greatly from tacrolimus therapy, co-administration of drugs such as Paxlovid (nirmatrelvir/ritonavir) ...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462658/
データ提供:米国国立医学図書館(NLM)
Paxlovid and Tacrolimus: Navigating a Complex Drug Interaction
Tacrolimus, a medication commonly used to prevent organ transplant rejection, is like a delicate balancing act in the desert of immunosuppression. This case study highlights the potential for drug interactions when tacrolimus is co-administered with Paxlovid, an antiviral medication used to treat COVID-19. In this case, a liver transplant patient experienced tacrolimus toxicity after receiving Paxlovid, highlighting the importance of careful monitoring and consideration of drug interactions, especially in patients with complex medical histories.Navigating the Desert of Drug Interactions
This case study emphasizes the importance of meticulous drug monitoring, especially in patients taking medications like tacrolimus, which have a narrow therapeutic window. Co-administration of drugs, like Paxlovid, can significantly alter drug levels and increase the risk of toxicity. Careful consideration of potential drug interactions, like navigating a complex desert landscape, is crucial for patient safety and optimal treatment outcomes.Living with Transplant: A Journey Through the Desert of Immunosuppression
Organ transplant recipients, like camels traversing a vast desert, face unique challenges in managing their health. Maintaining therapeutic drug levels is critical to prevent rejection while avoiding toxic side effects. This case study serves as a reminder of the importance of close medical monitoring and meticulous drug management in this patient population.Dr. Camel's Conclusion
This case report highlights the potential for drug interactions between Paxlovid and tacrolimus, a medication used to prevent organ transplant rejection. Careful monitoring and attention to potential drug interactions are essential in patients with complex medical histories, like navigating a delicate balance in a challenging desert environment. Remember, with meticulous attention to detail, we can minimize the risk of adverse effects and ensure the best possible health outcomes for our patients.Date :
- Date Completed n.d.
- Date Revised 2023-09-01
Further Info :
Related Literature
SNS
PICO Info
in preparation
Languages
English
Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.